Myocardial and liver iron status using a fast T2* quantitative MRI (T2*qMRI) technique

Magnetic Resonance in Medicine

Volumn 57, Issue 4, 2007, Pages 742-753

  Maris, Thomas G ^a,c   Papakonstantinou, Olympia ^a   Chatzimanoli, Vasiliki ^a   Papadakis, Alekos ^b   Pagonidis, Konstantinos ^a   Papanikolaou, Nickolas ^a   Karantanas, Apostolos ^a   Gourtsoyiannis, Nicholas ^a  

^a UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

^b Venizelion General Hospital   (Greece)

^c UNIVERSITY OF CRETE   (Greece)

Author keywords

Cardiac mr imaging; Cardiac t2*; Cardiomyopathy; Measurements; Myocardial hemosiderosis; Thalassemia

Indexed keywords

ELECTROCARDIOGRAPHY; MAGNETIC RESONANCE IMAGING; MEASUREMENT;

BREATH HOLDS; CARDIAC MR; CARDIOMYOPATHY; GRADIENT ECHO; IRON DEPOSITION; MYOCARDIAL HEMOSIDEROSIS; QUANTITATIVE MRIS; THALASSEMIA;

MUSCLE;

FERRITIN;

ADOLESCENT; ADULT; ARTICLE; BLOOD TRANSFUSION; CLINICAL ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; ELECTROCARDIOGRAM; FEMALE; FERRITIN BLOOD LEVEL; HEART FUNCTION; HUMAN; IMAGE ANALYSIS; LIVER FUNCTION; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; QUANTITATIVE ANALYSIS; THALASSEMIA; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

EID: 34248356266     PISSN: 07403194     EISSN: 15222594     Source Type: Journal    
DOI: 10.1002/mrm.21204     Document Type: Article

References (40)

1. Zurlo MG, De Stefano P, Borgna-Pignatti C, Di Palma A, Piga A, Melevendi C, Di Gregorio F, Burattini MG, Terzoli S. Survival and causes of death in thalassemia major. Lancet 1989;8653:27-30.
2. Kremastinos D, Tsetsos G, Tsiaparas D, Karavolias G, Ladis V, Kattamis C. Heart failure in β-thalassemia: a 5-year follow-up study. Am J Med 2001;111:349-354.
3. Borgna-Pignatti C, Rugolotto S, De Stefano P, Zhao H, Cappellini MD, Del Vecchio GC, Romeo MA, Forni GL, Gamberini MR, Ghilardi R, Piga A, Cnaan A. Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine. Haematologica 2004; 89:1187-1193.
4. Aldouri MA, Wonke B, Hoffbrand AV, Flynn DM, Ward SE, Agnew JE, Hilson AJ. High incidence of cardiomyopathy in beta-thalassemia patients receiving regular transfusion and iron chelation: reversal by intensified chelation. Acta Haematol 1990;84:113-117.
5. Davis BA, Porter JB. Long-term outcome of continuous 24-hour desferrioxamine infusion via indwelling intravenous catheters in high risk beta-thalassemia. Blood 2000;95:1229-1236.
6. Porter JB, Davis BA. Monitoring chelation therapy to achieve optimal outcome in the treatment of thalassemia. Best Pract Res Clin Haematol 2002;15:329-368.
7. De Virgillis S, Sanna G, Cormacchia C, Argiolu F, Murgia V, Porcu M, Cao A. Serum ferritin, liver iron stores, and liver histology in children with thalassemia. Arch Dis Child 1980;55:43-45.
8. Barry M, Sherlock S. Measurement of liver-iron concentration in needle-biopsy specimens. Lancet 1971;1:100-103.
9. Brissot P, Deugnier Y. Haemochromatosis. In: Mcintyre N, Benhamou JP, Bircher J, Rizzetto M, Rodes J, editors. Oxford textbook of clinical hepatology. Oxford: Oxford University Press; 1999. p 1979-1991.
10. Guyader D, Gandon Y, Deugnier Y, Jouanolle H, Loreal O, Simon M, Bourel M, Carsin M, Brissot P. Evaluation of computed tomography in the assessment of liver iron overload: a study of 46 cases of idiopathic hemochromatosis. Gastroenterology 1989;97:737-743.
11. Brittehham GM, Farrell DE, Harris JW, Feldman ES, Danish EH, Muir WA, Tripp JH, Bellon EM. Magnetic susceptibility measurement of human iron stores. N Engl J Med 1982;307:1671-1675.
12. Fischer R, Tiemann CD, Engelhardt R, Nielsen P, Durken M, Gabbe EE, Janka GE. Assessment of iron stores in children with transfusion siderosis by biomagnetic liver susceptometry. Am J Haematol 1999;60: 289-299.
13. Fischer R, Longo F, Nielsen P, Engelhardt R, Hider RC, Piga A. Monitoring long-term efficacy of iron chelation therapy by deferiprone and desferrioxamine in patients with beta-thalassaemia major: application of SQUID biomagnetic liver susceptometry. Br J Haematol 2003;121: 938-948.
14. Stark DD, Moseley ME, Bacon BR, Moss AA, Goldberg HI, Bass NM, James TL. Magnetic resonance imaging and spectroscopy of hepatic iron overload. Radiology 1985;154:137-142.
15. Kaltwasser PJ, Gottschalk R, Schalk PK, Hartl W. Non-invasive quantitation of liver iron-overload by magnetic resonance imaging. Br J Haematol 1990;74:360-363.
16. Stark DD. Hepatic iron overload: paramagnetic pathology. Radiology 1991;179:333-335.
17. Gomori JM, Horev G, Tamary H, Zandback J, Kornreich L, Zaizov R, Freud E, Krief O, Ben-Meir J, Rotem H, Kuspet M, Rosen P, Rachmilewitz EA, Loewenthal E, Gorodetsky R. Hepatic iron overload: quantitative MR imaging. Radiology 1991;179:367-369.
18. Jensen PD, Jensen FT, Christensen T, Ellegaard J. Non-invasive assessment of tissue iron overload in the liver by magnetic resonance imaging. Br J Haematol 1994;87:171-184.
19. Papakonstantinou OG, Maris TG, Kostaridou V, Gouliamos AD, Kotoulas GK, Kalovidouris AE, Papavassiliou GB, Kordas G, Kattamis C, Vlahos LJ, Papavassiliou CG. Assessment of liver iron overload by T2-quantitative magnetic resonance imaging: correlation of T2-qMRI measurements with serum ferritin concentration and histologic grading of siderosis. Magn Reson Imaging 1995;13:967-977.
20. Ernst O, Sergent G, Bonvarlet P, Canva-Delcambre V, Paris J, L'Hermine C. Hepatic iron overload: Diagnosis and quantification with MR imaging. AJR Am J Roentgenol 1997;168:1205-1208.
21. Mavrogeni SI, Maris T, Gouliamos A, Vlahos L, Kremastinos DT. Myocardial iron deposition in β-thalassemia studied by magnetic resonance imaging. Int J Cardiac Imaging 1998;00:1-6.
22. Mavrogeni SI, Gotsis ED, Markussis V, Tsekos N, Politis C, Vretou E, Kremastinos D. T2 relaxation time study of iron overload in b-thalassemia. Magn Reson Mater Biol Physics Med 1998;6:7-12.
23. Bonkovsky LH, Rubin BR, Cable EE, Davidoff A, Pels Rijcken HT, Stark DD. Hepatic iron concentration: non invasive estimation by means of MR imaging techniques. Radiology 1999;212:227-234.
24. Papanikolaou N, Chiatas A, Kattamis A, Ladis C, Kritikos N, Kattamis C. T2 relaxometry and magnetization transfer ratio measurements. Acta Radiol 2000;41:348-351.
25. Anderson LJ, Holden S, Davis B, Prescott E, Charrier CC, Bunce NH, Firmin DN, Wonke B, Porter J, Walker JM, Pennell DJ. Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J 2001;22:2171-2179.
26. Anderson LJ, Wonke B, Prescott E, Holden S, Walker JM, Pennell DJ. Comparison of effects of oral deferiprone and subcutaneous desferrioxamine on myocardial iron concentrations and ventricular function in beta-thalassaemia. Lancet 2002;360:516-520.
27. Westwood M, Anderson LJ, Firmin DN, Gatehouse PD, Charrier CC, Wonke B, Pennell DJ. A single breath-hold multiecho T2* cardiovascular magnetic resonance technique for diagnosis of myocardial iron overload. J Magn Reson Imaging 2003;18:33-39.
28. Westwood MA, Anderson LJ, Firmin DN, Gatehouse PD, Lorenz CH, Wonke B, Pennell DJ. Interscanner reproducibility of cardiovascular magnetic resonance T2* measurements of tissue iron in thalassemia. J Magn Reson Imaging 2003;18:616-620.
29. Gandon Y, Olivie D, Guyader D, Aube C, Oberti F, Sebille V, Deugnler Y. Non-invasive assessment of hepatic iron stores by MRI. Lancet 2004;363:357-362.
30. Alustiza JM, Artexte J, Castiella A, Agirre C, Emparanza JI, Otazua P, Garcia-Bengoechea M, Barrio J, Mujica F, Recondo JA. MR quantification of hepatic iron concentration. Radiology 2004;230:479-484.
31. Voskaridou E, Douskou M, Terpos E, Papassotiriou I, Stamoulakatou A, Ourailidis A, Loutradi A, Loukopoulos D. Magnetic resonance imaging in the evaluation of iron overload in patients with beta thalassaemia and sickle cell disease. Br J Haematol 2004;126:736-742.
32. Anderson LJ, Westwood MA, Holden S, Davis B, Prescott E, Wonke B, Porter JB, Walker JM, Pennell DJ. Myocardial iron clearance during reversal of siderotic cardiomyopathy with intravenous desferrioxamine: a prospective study using T2* cardiovascular magnetic resonance. Br J Haematol 2004;127:348-355.
33. Mavrogeni SI, Markussis V, Kaklamanis L, Tsiapras D, Paraskevaidis I, Karavolias G, Karagiorga M, Douskou M, Cokkinos DV, Kremastinos DT. A comparison of magnetic resonance imaging and cardiac biopsy in the evaluation of heart iron overload in patients with β-thalassemia major. Eur J Haematol 2005;75:241-247.
34. Bevington PR. Data reduction and error analysis for the physical sciences. New York: McGraw-Hill; 1969. p 69-77, p 102-110.
35. Kaufman L, Kramer DM, Crooks EL, Ortendahl DA. Measuring signal to noise ratios in MR imaging. Radiology 1989;173:265-267.
36. Reeder SB, Faranesh AZ, Boxerman JL, McVeigh ER. In vivo measurement of T2* and field inhomogeneity maps in the human heart at 1.5 T. Magn Reson Med 1998;39:988-998.
37. Bauer RW, Nadler W, Bock M, Schad RL, Wacker C, Hartlep A, Ertl G. Theory of BOLD effect in the capillary region: an analytical approach for the determination of T2* in the capillary network of myocardium. Magn Reson Med 1999;41:51-62.
38. Wacker CM, Bock M, Hartlep AW, Beck G, Van Kaick G, Ertl G, Bauer WR, Schad LR. Changes in myocardial oxygenation and perfusion under pharmacological stress with dipyridamole: Assessment using T2* and T1 measurements. Magn Reson Med 1999;41:686-695.
39. Guyton CA, Hall EJ. Textbook of medical physiology. 11th ed. Philadelphia: Elsevier Saunders; 2006. p 106-107.
40. Guyton CA, Hall EJ. Textbook of medical physiology. 11th ed. Philadelphia: Elsevier Saunders; 2006. p 125-126.